Sirma Group Holding JSC. Consolidated financial statements for the year ending December 31, 2016
|
|
- Arron Conley
- 5 years ago
- Views:
Transcription
1 Sirma Group Holding JSC Consolidated financial statements for the year ending December 31, 216
2 Changes in share prices for the period ending Last trading price on BGN Change in share price for the period -,11 BGN Volume BGN 52W High 52W Low.85 BGN 1.25 BGN Weighted-average price Market capitalization 7 58 BGN 2
3 Shareholder s capital distribution as of BGN Shareholder s capital Shares (with nominal price BGN 1.) 777 Shareholders individual 735 corporate investors 42 Number of shares held by 11,1% corporate investors 88,99% Number of shares held by individuals 3
4 Key events during 216 Sirma ICS Launch of a new daughter company of Sirma Solutions Sirma ICS, with capital of BGN 5., subsequently increased to BGN 3., and main aim to become the leading technology partner of the insurance sector. Sirma Medical Systems Sirma Medical Systems with capital of BGN 1 and with the main goal to develop software for medical purposes and applications, which provide access to contemporary medical services Sirma Solutions "Sirma Solutions" JSC increased its capital by BGN Ontotext The Board of directors of Sirma Group Holding has taken a decision to participate in the capital increase of Ontotext with shares with par value 1 BGN and issue price 1.16 BGN Sirma Group Inc 7.16 Sirma Enterprise Systems Sirma Group Inc Sirma Group Inc. in USA with capital USD 2 million and with main goal of increasing sales of the products and services of the companies in the Group on the American and neighboring markets through the creation of a strong sales team. "Sirma ITT" JSC changed its name to "Sirma Enterprise Systems" JSC Sirma Group Inc has opened new office in New Jersey, USA 4
5 Consolidated Financial Results for the period ending BGN in thousands BGN BGN in thousands in thousands 195,31% BGN in thousands % +233% BGN in thousands Margin 31% 3.2% Margin ,8% % ,7% 5
6 Geographic Revenue Breakdown Revenue by region in thousand BGN North America Bulgaria ,21% ,53% GROWTH 59,6% ,29% GROWTH Europe Others ,64% % GROWTH 1,55% ,77% GROWTH : BGN 216: BGN SALES in thousands 195,31% GROWTH 6
7 Revenue Breakdown by Companies BGN 7,81% BGN 6,26% BGN 4,42% BGN 8,18% USA BGN 44,22% 3 55 BGN 6,96% 2 85 BGN 5,58% 722 BGN 1,41% * BGN % vs 215 unconsolidated revenue BGN 12,7% BG 7
8 Re-classification of the strategic segments Old Segment New Segment CAD/CAM Manufacturing & Utility Data Center Cross Industry Healthcare Life Sciences Corporate Software Ontology & Semantics Products System Integration Software Services & Consulting Fintech Cross Industry Finance Manufacturing & Utility Life Sciences Publishing & Media Cross Industry Manufacturing & Utility Publishing & Media Life Sciences Cross Industry Public Sector Public Sector Cultural Heritage Cross Industry Publishing & Media Life Sciences Manufacturing & Utility Public Sector Finance 8
9 Key Financial Data BGN Приходи Нетна печалба Ръест на приодите, % Net profit 9
10 The Companies from the Group During the period ending December 31, 216
11 Key Financial (Individual) Data 216 vs BGN % 21: 1 76 BGN BGN % 21: 133 BGN 382 BGN + 267% 21: 14 BGN * Key Highlights Margin Margin BGN % 21: 94 BGN 51,9% + 32% 21: 12.4% 39,4% + 351% 21: 8.7% Sirma Group Inc was established in the USA, with a focus on the distribution of the products and services of the holding s companies. The Sirma Medical Company was established, specializing in software for the monitoring of chronic diseases. BGN raised from the IPO were invested as it follows: investment of 387 thousand BGN in start-ups; investment of 6336 thousand BGN in intangible assets; 1,1 thousand BGN - Investments in increasing the capital of subsidiary companies with aim to boost capacity 11
12 Key Financial Data 216 vs 21 Margin Margin BGN + 174% 21: BGN 7 33 BGN + 419% 21: 1 46 BGN BGN + 3% 21: 1 21 BGN BGN % 21: 19 BGN 32.4% + 89% 21: 17.1 % 1.7% + 77% 21: 1.3 % Key Highlights 216 Launch of a new company Sirma ICS with current capital of BGN 3.. Sales of hardware, licenses and system integration services reach BGN 15 million in 216. The LOYAX R&D unit is fully set up for a spin-off into a separate company. The company is continuing its R&D into the computer vision and AI sphere. Finalization of the Alpha version of a product targeting the North American market with release due in
13 Key Financial (consolidated) Data 216 vs BGN + 122,52% 21: 3 46 BGN Margin BGN + 181,66% 21: 758 BGN BGN % Net Profit Key Highlights : 643 BGN 479 BGN + 393,81% 21: 97 BGN 31,5% + 26,58% 21: 24.9% Margin The British Institute of Engineering and Technology, Springer-Neptune, and Elsevier became clients, thus 5 out of the 1 leading publishing houses for scientific literature the world over use GraphDB. Together with ImpelSys was started a project on the development of integrated technological solutions to contents publishing. Preparation of applications for the financial and pharmaceutical industries for sale in the USA. 7,1% + 121,92% 21: 3.2% 13
14 Key Financial Data 216 vs BGN % 21: BGN 528 BGN % 21: 12 BGN BGN % 21: 377 BGN Key Highlights 216 Margin Margin 112 BGN 21: BGN 14.2% % 21:.5% 3.% 21: % Three successful projects for the implementation of the SCARDS product Developing a product for IRFS9 and new accounts for the ECB. Implementation of Omni Channel Trinidad and Tobago. Successful migration of Flex Cube to Albania. Successful licensing of 8 employees for FC
15 Key Financial Data 216 vs 214 The company started its economic activity in 214 Енг Вю Системс 3 55 BGN % 214: BGN 914 BGN % 214: 15 BGN NA Key Highlights 216 Margin Margin 91 BGN % 214: 9 BGN 25.7% % 214:.6% 25.6% % 214:.4% A new project for the development of an end-user-oriented product in the field of "cyber security". The product is intended for handling major challenges related to the protection of home networks and sensitive data. A new project for the establishment of Call Center Solutions together with a medium-size American company Enlargement of the teams working for the Vatillum and Elevada clients. A new project with a company dealing with radio frequency measurements in the field of the mobile industry. The objective of the project is to unite the instruments the company affords to its clients into one combined "cloud" platform. A new project with a company which is a leading provider of cloud-based wire and wireless WAN network solutions for "Distributed and Mobile Enterprises 15
16 Key Financial Data 216 vs 21 Margin Margin BGN % 21: BGN 582 BGN % 21: 221 BGN 13 BGN % 21: 12 BGN 432 BGN % 21: 23 BGN 18.2% % 21: 15.1% 13.5% % 21: 13.9% Key Highlights 216 Preparation of an EngView product portfolio for the American market. Launch of the Мас version of EngView Package & Display Designer Suite. Participation in the Drupa Exhibition in Dusseldorf, which led to a lot of new contacts and partnerships. Signing of contracts for distribution in Hungary and Malasia. A signed ОЕМ contract with the German producer of plotters, Aristo. Through its distributor in Japan, EngView implemented its software for packaging and displays, as well as for the needs of the biggest Japanese producer of cutting plotters, ACS. A strong interest on the part of the USA in another product of EngView Systems ScanFit, which was displayed at the specialized exhibitions in Chicago and Boston Q4 216 Q3 216 Q2 216 Q1 216 Q4 215 Q3 215 Q2 215 Q Приходи Нетна печалба
17 Key Financial Data 216 vs BGN + 2% 21: 95 BGN 96 BGN % 21: 347 BGN BGN % 21: 325 BGN Key Highlights 216 Margin Margin 474 BGN % 21: 23 BGN 31.79% % 21: 36.5% 16.63% % 21: 2.4% Launch of Flash Storage service the only one in Bulgaria which allows the speed of 1М IOPS to our clients on the cloud platform. Launch of the new Disaster Recovery as a Service. Together with a partner, a launch of an innovative service for the Bulgarian market Microsoft Navision ERP as a Service. Increase of the company personnel by 2%. Opening of a second office 4 km away from Sofia, with a view to affording geographically reserved services. Datacum joins CISPE's Code of Conduct along with other leading cloud service providers. 17
18 Key Financial Data 216 vs BGN + 39% 21: BGN 1 43 BGN NA 21: BGN 687 BGN % 21: 43 BGN Key Highlights Margin Margin 21 BGN NA 21: - 41 BGN 46.19% NA 21: % 9.31% NA 21: % Change of the Sirma ITT name and rebranding. Launching of version 2 of Sirma Enterprise Platform. Developing a new application for management of documents intended for SME in the USA based on the Sirma Enterprise Platform Go Digital. Developing a new system for electronic services based on Sirma Enterprise Platform. 18
19 Thank you for your attention! We would be happy to address all your questions now: sirmair
Coloplast A/S. Investor presentation 1H 2005/06
Coloplast A/S Investor presentation 1H 2005/06 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 4 areas: Ostomy care, continence care, wound
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationLetter to Shareholders SEMI-ANNUAL REPORT 2008
Letter to Shareholders SEMI-ANNUAL REPORT 2008 Dear Shareholder You have in your hand the first shareholder letter issued by Nobel Biocare. Thanks to the conversion of Nobel Biocare s bearer shares into
More informationMANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.
MANAGEMENT MGMT 0021 THE MANAGEMENT PROCESS 3 cr. An introduction designed to emphasize the basic principles, practices, and terminology essential to the understanding of contemporary business and its
More informationFY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009
FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009 Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A)
More informationFor personal use only
ASX RELEASE (23 rd March 2018) AGM PowerPoint Presentaion In accordance with the requirements of Listing Rule 3.1 we submit the attached material being distributed at the Company s Annual General Meeting
More informationGN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008
GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company
More informationInvestor Presentation
ASX:THC B u i l d i n g a M e d i c i n a l C a n n a b i s B u s i n e s s Investor Presentation November 2017 DISCLAIMER The material in this presentation (material) is not and does not constitute an
More informationWilliam Demant. Jefferies Healthcare Conf. Nov Søren B. Andersson, VP Investor Relations
William Demant Jefferies Healthcare Conf. Nov. 2017 Søren B. Andersson, VP Investor Relations Agenda General update Key take-aways from November Interim Statement Hearing Devices Outlook 2017 Q&A 2 General
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and
More informationConsolidated: Financial Summary
FY2010 First Quarter Financial Results SUZUKI MOTOR CORPORATION 3 August 2010 Consolidated: Financial Summary Page2 FY2010 1Q FY2009 1Q (2010/4-6) (2009/4-6) Change Net sales 656.3 577.1 +79.2 +13.7% Operating
More informationHILLENBRAND INDUSTRIES INC
HILLENBRAND INDUSTRIES INC FORM 8-K (Unscheduled Material Events) Filed 2/17/2004 For Period Ending 2/13/2004 Address 700 STATE ROUTE 46 E BATESVILLE, Indiana 47006-8835 Telephone 812-934-7000 CIK 0000047518
More information1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes
1Q 2015 Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes Forward-Looking Statements and Copyright This Presentation includes and is based, inter alia, on forward-looking information and statements
More informationEurope Tooth Shade Scanners Industry 2016 Market Research Report
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Europe Tooth Shade Scanners Industry Market Research Report Europe Tooth Shade Scanners Industry Market Research
More informationDIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM
November 28, 2017 DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM Dr. Jürgen Wunram Agenda Diebold Nixdorf AG History and shareholder structure Market trends, strategy and progress of integration Diebold Nixdorf
More informationJanuary 30, 2018 Dow Wilson President and Chief Executive Officer
Acquisition of SIRTeX January 30, 2018 Dow Wilson President and Chief Executive Officer This presentation is intended exclusively for investors. It is not intended for use in Sales or Marketing. Forward-Looking
More informationFor personal use only
Cochlear Limited Results for the half year ended 31 December 2011 (H1 F12) Chris Roberts, CEO Neville Mitchell, CFO Cochlear Overview Cochlear Limited (ASX:COH): global leader in implantable devices for
More informationFor personal use only
Australian Securities Exchange Limited Companies Announcements Office SYDNEY 4 April, 2012 New Australian Drug Developer Lists on ASX Key points Growth-focused Australian drug and therapeutic development
More informationSPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS
SPHERIX Investor Relations Phone: (301) 897-2564 Email: info@spherix.com SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS BETHESDA, MD, May 21, 2010 - Spherix Incorporated (NASDAQ CM: SPEX), an innovator
More informationSumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical
For immediate release November 25, 2004 Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical Sumitomo Chemical Co., Ltd. announced today that its subsidiary, Sumitomo
More informationSpiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria
Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi
More informationGlobal Vitamin Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Vitamin Market Professional Survey Report 2016 Global Vitamin Market Professional Survey Report 2016 Publication
More informationFinancial Results of the Asseco Group for the 1 st quarter of Warsaw, 14 May 2009
Financial Results of the Asseco Group for the 1 st quarter of 2009 Warsaw, 14 May 2009 Agenda Summary of the 1 st quarter of 2009 Nearest plans 2 Financial highlights Consolidated data Sales* Proprietary
More informationValue creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO
Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue
More informationMexico Milling Machine for Dental Clinics Industry 2016 Market Research Report
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Mexico Milling Machine for Dental Clinics Industry Market Research Report Mexico Milling Machine for Dental Clinics
More informationForward Looking Information
Vital Signs, Inc. Forward Looking Information Except for historical information discussed, the statements made today are forward-looking statements that involve risks and uncertainties. Investors are cautioned
More informationeclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
eclinical Solutions Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Projected to grow at a CAGR of around 12%, eclinical solutions market is expected to witness significant
More informationIncrease in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014
Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) ( ) H1 2014 revenues and results - 24 July 2014 Forward-looking statement This presentation contains
More informationOperational Efficiency:
Operational Efficiency: metrics that matter Copyright Altus Ltd 214. All rights reserved. Kevin Okell Consultancy Director 15/5/214 From distribution chain to value chain Ad-valorem pricing driven from
More informationAcquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions
Acquisition of BP s Interests in Bruce, Keith and Rhum Fields in the North Sea Frequently Asked Questions 1. What is Serica buying? Serica Energy is buying the Bruce, Keith and Rhum (BKR) package of assets
More informationShareholder Presentation Annual Meeting 2018
Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationCorporate Presentation October New growth cycle and value innovation
Corporate Presentation October 2017 New growth cycle and value innovation Index 1 Dental benefits: an incipient sector in Brazil 2 Inside OdontoPrev 3 Strategic competitive advantages 4 Financial and Operational
More informationChina Portable Medical Electronic Devices Industry Report, 2010
China Portable Medical Electronic Devices Industry Report, 2010 Portable medical electronic devices can be mainly divided into home type and professional type, of which, the former covers electronic sphygmomanometer,
More informationINVESTOR PRESENTATION
INVESTOR PRESENTATION May 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities regulation.
More informationELICA 2012 Q3 RESULTS. November 14,
ELICA ELICA 1 Q3 12 Highligths Negative market demand, showing better trend compared to previous quarters Group sales over performing in all major markets Cost reduction efforts and continued product innovation
More informationGlobal Standard Radiography Film X-Ray Film Printer Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Standard Radiography Film X-Ray Film Printer Market Research Report 2016 Global Standard Radiography Film
More informationUnited States Tuberculosis Vaccine Industry 2016 Market Research Report
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > United States Tuberculosis Vaccine Industry 2016 Market Research Report United States Tuberculosis Vaccine Industry
More informationInvestor Presentation
Investor Presentation February 2018 2 FORWARD-LOOKING INFORMATION The following presentation contains statements that are considered forward-looking information ( FLI ) within the meaning of securities
More informationartnet AG Quarterly Interim Statement for the First Quarter of 2017 artnet AG Quarterly Interim Statement for the First Quarter of 2017
Quarterly Interim Statement for the First Quarter of 2017 Quarterly Interim Statement for the First Quarter of 2017 Table of Contents General Information and Business Activities Economic Development of
More informationGlobal Oil Softgel Capsules Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Oil Softgel Capsules Market Research Report 2016 Global Oil Softgel Capsules Market Research Report 2016
More informationValneva Reports Strong Q1 Revenue Growth and Positive EBITDA Reaffirms Financial Guidance and Pipeline Outlook for 2017
Valneva Reports Strong Q1 Revenue Growth and Positive EBITDA Reaffirms Financial Guidance and Pipeline Outlook for 2017 Robust Q1 financial results confirming financial self-sustainability strategy Total
More informationGlobal Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Magnetic Resonance Imaging (MRI) Systems Market Research Report 2016 Global Magnetic Resonance Imaging (MRI)
More informationInterim report Second quarter 2017 and subsequent events (Unaudited)
SERODUS ASA Interim report Second quarter 2017 and subsequent events (Unaudited) August 2017 2017-08-15 Q2-2017 report ABOUT SERODUS Serodus is a private biotech company with a focus on diabetic comorbidities
More informationColoplast A/S. Investor Presentation 2005/06
Coloplast A/S Investor Presentation 2005/06 2 Coloplast in brief Coloplast s products and services help patients achieve greater independence from medical challenges in 4 areas, ostomy care, urology &
More informationInvestor Day EEMA Region Lausanne, September 29, Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free
Investor Day EEMA Region Lausanne, September 29, 2016 Drago Azinovic President, Eastern Europe, Middle East & Africa Region & PMI Duty Free Agenda Overview and Key Results Vision and Strategic Pillars
More informationInvestor Relations 1Q 2017
Investor Relations 1Q 2017 History Leading Authentic Sports Brand Inspired by the Style, Elegance and Passion of our Italian Heritage Founded by FILA brothers in Biella, Italy Established FILA Korea FILA
More informationTelekom Austria Group Results for the 1st Quarter May 27, 2003
Telekom Austria Group Results for the 1st Quarter 2003 May 27, 2003 1 Cautionary Statement This presentation contains certain forward-looking statements. Actual results may differ materially from those
More informationVisionary Private Equity Group is Pleased to Announce its Investment in MEDITE Cancer Diagnostics
Dear VPEG Limited Partner, We hope this investor update finds you well. We're pleased to share with you an important update below on the following: Visionary Private Equity Group is Pleased to Announce
More informationPutting ALK on the right growth trajectory
Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large
More informationCPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationUsing the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment
Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment Rachael Eckles, JD/MA Director, Regulatory Policy Bristol-Myers Squibb August 10,
More informationIndustry experience in consortium i.e. from BEE party or non-bee partners
A. ENTREPRENEURSHIP FINANCE Imbewu Entrepreneurship Finance would provides risk capital to new businesses and to early stage businesses owned and managed by black people meeting the following criteria:
More informationTo be the partner of choice Straumann
To be the partner of choice Straumann Gilbert Achermann, CEO Helvea Swiss Equities Conference 11 January 2008, Bad Ragaz Table of contents 1. A snapshot of Straumann 2. Financials 3. Markets and opportunities
More informationAccessibility of Communications in Canada Presentation to Accessible Americas III: Information and Communication for ALL
Accessibility of Communications in Canada Presentation to Accessible Americas III: Information and Communication for ALL Barbara Motzney, Chief Consumer Officer Canadian Radio-television and Telecommunications
More informationTotal Market Approach to Improving Family Planning Access in the Republic of Georgia
Total Market Approach to Improving Family Planning Access in the Republic of Georgia Presentation Outline Country context and FP/RH background Key strategies to improve family planning access Accomplishments
More informationDistribution Partner Briefing: A Partnership for Profit. Welcome to Smartcool s information package for prospective channel partners.
Distribution Partner Briefing: A Partnership for Profit Welcome to Smartcool s information package for prospective channel partners. This publication is intended only as a general guide to assist you in
More informationChina Human Vaccine Industry Report, July 2017
China Human Vaccine Industry Report, 2017-2021 2021 July 2017 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationThird-quarter results 2013
Third-quarter results 213 Fornebu, 6 November 213 Øyvind Eriksen and Leif Borge Agenda 213 Introduction Øyvind Eriksen Executive chairman Financials Leif Borge President & CFO Q&A Q&A session Øyvind Eriksen
More informationColoplast A/S. Investor Presentation Investormøde 16. Januar 2006
Coloplast A/S Investor Presentation Investormøde 16. Januar 2006 2 Defining Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 5 areas: Ostomy
More informationKey figures (consolidated)
Nestlé Group 2013 Key figures (consolidated) In millions of CHF (except for data per share) 2013 Results Sales 92158 Trading operating profit 14047 as % of sales 15.2% Profit for the year attributable
More informationFor personal use only. Investor Briefing. Bayswater, 1 st December 2016
Investor Briefing Bayswater, 1 st December 2016 Introduction Samantha Cheetham Chief Executive Officer To be an innovative leader in the dental industry, developing our people and partnering with dentists
More informationH. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports
More informationWelcome to iknowhow. Evorad Aurora Evolution in Radiology
Welcome to iknowhow Evorad Aurora Evolution in Radiology ehealth Neural Network Architecture Today, the ultimate challenge in the $6B (growing double digit) Global ehealth Industry is to find a way to
More informationWHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing
WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing Washington, DC January 14th 16th, 2013 Session 4: Attracting Investments and Generating Revenue Theory, Practice and
More informationAfter simple testing that only takes minutes people with elevated test results are then recommended to see their physicians for follow-up.
New Medical Device Company Addresses Two Very High Demand Markets with its Proprietary Products. Trader Tracks likes this company as they provide reasonably priced equipment and testing while medical costs
More informationEnvironmental, Health and Safety
Environmental, Health and Safety Codes of Practice The Environmental, Health and Safety (EHS) Codes of Practice set forth Zimmer EHS requirements for our business functions and facilities worldwide. In
More informationGlobal Patient Scales Market Research Report 2021
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Patient Scales Market Research Report 2021 Global Patient Scales Market Research Report 2021 Publication
More informationGrupo Fleury announces the acquisition of Grupo Papaiz, entering the dental diagnostics market. September 28th, 2012
Grupo Fleury announces the acquisition of Grupo Papaiz, entering the dental diagnostics market September 28th, 2012 All rights reserved 2012 Disclaimer This presentation may contain forward-looking statements.
More informationChronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA
Chronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA US Chronic Care has outperformed the market by a factor 2-3x and continues
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader
More information6.00% CAP Rate $5,600,000. DeerfieldPartners. John Giordani Art Griffith (415) Actual Store
Actual Store Low Price & Great Value $5,6, 6.% CAP Rate Open & paying rent--available for immediate sale Lower price point and great value Offered free & clear; loans available today with as little as
More informationObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update - All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland
More informationChina Human Vaccine Industry Report, Jun. 2016
China Human Vaccine Industry Report, 2016-2020 Jun. 2016 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationCompany presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018
Company presentation SEB Nordic Seminar Bella Sky, Copenhagen Carsten Hellmann, President & CEO 9 January 2018 Allergy: a global disease with a large unmet need >500 million people affected by allergic
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Company presentation Per Plotnikof, VP Corporate Communications and IR 1 I ALK at a glance Commercial leader and foremost innovator within respiratory allergies
More informationGlobal Cosmetic Dentistry Market Research Report 2018
Report Information More information from: https://www.wiseguyreports.com/reports/3029111-global-cosmetic-dentistry-market-research-report- 2018 Global Cosmetic Dentistry Market Research Report 2018 Report
More informationForward-Looking Statements
Investor Presentation May 2012 Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended.
More informationWntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE
Occasion: Initial coverage +37% +71% 100% one-week return? s share price has dropped by more than 50% since the announcement of the current and ongoing public offering. In theory the share price should
More informationMarketing Makeover. Look Good in a Crowded. Strategies that Make You. Cloud Marketplace
Proprietary information of Ingram Micro Inc. Do not distribute or duplicate without Ingram Micro s express written permission. Marketing Makeover Strategies that Make You Look Good in a Crowded Cloud Marketplace
More informationartnet AG Quarterly Interim Statement for the First Quarter of 2016 artnet AG Quarterly Interim Statement for the First Quarter of 2016
Quarterly Interim Statement for the First Quarter of 2016 Quarterly Interim Statement for the First Quarter of 2016 for Table of Contents General Information and Business Activities Economic Development
More informationStraumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010
Media release Straumann reports 4% growth in local currencies (l.c.) in the first nine months of 2010 Growth driven by implant volumes, lifted by Bone Level implant range and Roxolid Third quarter (+3%
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationTHIRD QUARTER REPORT 2011 (UNAUDITED)
THIRD QUARTER REPORT 2011 (UNAUDITED) Kronprinsesse Märthas pl. 1, Vika, 0166 Oslo, Norway. Tel: + 47 23 01 09 60, www.bionorpharma.com Page 1 THIRD QUARTER REPORT 2011 HIGHLIGHTS On the 25th August Bionor
More informationSoca Music: A competitive cultural tourism product?
Soca Music: A competitive cultural tourism product? Can the soca music cultural asset be transformed into an internationally competitive cultural tourism product? Presentation Outline Introduction/Background
More information1Q2017 法人說明會 Jun. 9, 2017
1Q2017 法人說明會 Jun. 9, 2017 FE group business Span over 10 major industries Own over 240 companies Established in 1937 9 public listed companies in Taiwan and HK Petrochemical & energy Polyester & synthetic
More information1Q2005. Hera Group presentation
1Q2005 Hera Group presentation 1 Y2005 has been characterized by a stream of achievements: Corporate Governance A new BoD was appointed in April. Further penetration of the Hera Gas market: 1,500 new clients
More informationBlood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, Single User License: US $ 4595
Transparency Market Research Blood Flow Measurement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019 Single User License: US $ 4595 Buy Now Request Sample
More informationGlobal Remote Cardiac Monitoring Market: Size, Trends & Forecasts ( )
Global Remote Cardiac Monitoring Market: Size, Trends & Forecasts (2016-2020) #910680 $800 55 pages In Stock Report Description Scope of the Report The report entitled Global Remote Cardiac Monitoring
More informationObsEva Reports First Quarter 2018 Financial Results and Provides Business Update
ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update -Key First Quarter 2018 Clinical Milestones Achieved Patient randomization completed in Phase 2b EDELWEISS trial of OBE2109
More informationInvestor Presentation June 2012 NASDAQ: CEMI
Investor Presentation June 2012 NASDAQ: CEMI Forward-Looking Statements Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act
More informationSchool of Management, NEW JERSEY INSTITUTE OF TECHNOLOGY Master of Science in Management (MSM)
School of Management, NEW JERSEY INSTITUTE OF TECHNOLOGY Master of Science in Management (MSM) Courses (30 credits) Semester Completed Note Requirement Module I: Core Courses (15 credits) ACCT 615 Management
More informationColoplast A/S. Carnegie Nordic Healthcare Seminar 31 May - 1 June
Coloplast A/S Carnegie Nordic Healthcare Seminar 31 May - 1 June 2 Coloplast Coloplast products and services help patients achieve greater independence from medical challenges in 5 areas: Ostomy care,
More informationA world leader in allergy immunotherapy. Jefferies Global Healthcare Conference, London : 19 November 2014 : Flemming Pedersen, CFO & EVP
A world leader in allergy immunotherapy ALK at a glance Leading allergy immunotherapy (AIT) specialist AIT: Treats the root cause of allergy Products in all areas of AIT ALK has 33% of the global AIT market
More informationCOMPANY PROFILE. AL SHAMS Group
COMPANY PROFILE AL SHAMS Group Al Shams Pharma Scintific Bureau Shams Al-Ibdaa Drug Store Bilim Pharma Co. Al-Shams Drug Store Al-Murjan Drug Store Al-Aqsa Pharmacy & Cosmetic Al-Khadraa Pharmacy & Cosmetic
More informationGene Techno Science Co., Ltd.
Gene Techno Science Co., Ltd. Execution of Share Exchange Agreement and Conversion of Advanced Cell Technology and Engineering into Wholly- Owned Subsidiary of Gene Techno Science January 17 th, 2019 Cautionary
More informationSMART Communities Need A SMART Workforce Partners in SMART Education and Workforce Development & Training
SMART Communities Need A SMART Workforce Partners in SMART Education and Workforce Development & Training Who We Are What We Do SMART Community Exchange (SCE) founded in 2009, is an independent Public
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More information